You have 9 free searches left this month | for more free features.

Erythropoietin stimulating agents

Showing 1 - 25 of 8,319

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

Recruiting
  • Myelodysplastic Syndromes
  • Canakinumab Injection
  • Darbepoetin Alfa
  • Tampa, Florida
    Moffitt Cancer Center
Nov 21, 2022

Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis

Not yet recruiting
  • Erythropoietin Resistant Anemia (EPO Resistant Anemia)
    • (no location specified)
    Sep 22, 2023

    Erythropoiesis Stimulating Agents for Anemia Management in

    Completed
    • Anemia of Chronic Kidney Disease
    • +2 more
      • Giza, Egypt
        the Memorial Souad Kafafi University Hospital
      Jan 24, 2023

      Anemia of Chronic Kidney Disease Trial in Hackensack (Vadadustat)

      Suspended
      • Anemia of Chronic Kidney Disease
      • Hackensack, New Jersey
        Research Site
      Aug 23, 2022

      Hemodialysis Complication Trial in Mansoura (pentoxifylline)

      Not yet recruiting
      • Hemodialysis Complication
      • Mansoura, Egypt
        Mansoura University Hospital
      Feb 2, 2023

      Anemia, Sickle Cell, Sickle Cell Disease Trial in Pittsburgh, Lagos (Hydroxyurea, Epoetin Alfa)

      Not yet recruiting
      • Anemia, Sickle Cell
      • Sickle Cell Disease
      • Pittsburgh, Pennsylvania
      • +1 more
      Aug 4, 2022

      Renal Failure Chronic, Anemia Trial (Iron Sucrose Solution for Injection, Epoetin Beta)

      Completed
      • Renal Failure Chronic
      • Anemia
      • Iron Sucrose Solution for Injection
      • Epoetin Beta
      • (no location specified)
      Jun 27, 2019

      Anemia Renal Trial (Trental 400 MG Extended Release Oral Tablet)

      Unknown status
      • Anemia Renal
      • Trental 400 MG Extended Release Oral Tablet
      • (no location specified)
      Sep 24, 2019

      Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

      Not yet recruiting
      • Poor Graft Function
      • (no location specified)
      Jun 8, 2023

      MDS Trial in Beijing (Roxadustat, Luspatercept)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Beijing, China
        Peking union medical college hospital
      Aug 17, 2023

      MDS Trial (Imetelstat)

      Available
      • Myelodysplastic Syndromes
      • (no location specified)
      Jun 30, 2023

      Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

      Not yet recruiting
      • Poor Graft Function
      • (no location specified)
      Dec 29, 2022

      Anemia Trial in Anyang-si (Ferric Derisomaltose Injection, Darbepoetin Alfa Injection)

      Recruiting
      • Anemia
      • Ferric Derisomaltose Injection
      • Darbepoetin Alfa Injection
      • Anyang-si, Korea, Republic of
        Hallym University Medical Center
      Mar 13, 2023

      Anaemia, Haemodialysis Trial in London (Iron sucrose, Erythopoietin stimulating agent)

      Completed
      • Anaemia
      • Haemodialysis
      • Iron sucrose
      • Erythopoietin stimulating agent
      • London, United Kingdom
      • +1 more
      Mar 19, 2021

      End Stage Renal Disease Trial in Kaohsiung (AI (model))

      Completed
      • End Stage Renal Disease
      • AI (model)
      • Kaohsiung, TW, Taiwan
        Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
      Aug 31, 2021

      Anemia Trial in Palma de Mallorca (Paricalcitol, Epoetin beta, Placebo)

      Recruiting
      • Anemia
      • Palma de Mallorca, Islas Baleares, Spain
        Son Espases University Hospital
      Mar 3, 2021

      Erythropoietin Responsiveness in Children on Hemodialysis at

      Not yet recruiting
      • Pediatric Patients on Hemodialysis
      • seum zinic,vit B12, parathyriod function
      • Sohag, Egypt
        Sohag University Hospital
      Mar 28, 2022

      Anemia of Chronic Kidney Disease Trial in New Delhi (Recombinant human erythropoietin, Darbepoetin Alfa)

      Completed
      • Anemia of Chronic Kidney Disease
      • Recombinant human erythropoietin
      • Darbepoetin Alfa
      • New Delhi, Delhi, India
        Sir Ganga Ram Hospital
      Jul 10, 2021

      Anemia, Cancer Trial (Ferric carboxymaltose (FCM))

      Completed
      • Anemia
      • Cancer
      • Ferric carboxymaltose (FCM)
      • (no location specified)
      Dec 8, 2021

      Anemia Trial in Worldwide (Vadadustat, Darbepoetin alfa)

      Completed
      • Anemia
      • Chula Vista, California
      • +58 more
      Nov 10, 2022

      End Stage Renal Disease on Dialysis Trial in Kaohsiung, (novel artificial intelligence assisted platform)

      Recruiting
      • End Stage Renal Disease on Dialysis
      • novel artificial intelligence assisted platform
      • Kaohsiung,, Taiwan
        Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
      Oct 5, 2021

      MDS (MDS) Trial in United Kingdom (Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol)

      Recruiting
      • Myelodysplastic Syndromes (MDS)
      • Sodium Valproate, Bezafibrate, Medroxyprogesterone
      • Danazol
      • Dudley, England, United Kingdom
      • +7 more
      Aug 12, 2022

      Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)

      Recruiting
      • Anemia in Dialysis-dependent CKD Patients
      • Alexandria, Egypt
        Alexandria University
      Oct 29, 2023

      Anemia Trial (ESA for correction of PTA to 12-13g/dl)

      Completed
      • Anemia
      • ESA for correction of PTA to 12-13g/dl
      • (no location specified)
      Mar 1, 2019

      Erythropoietin-Iron Interaction in Anemia of Renal Disease

      Active, not recruiting
      • Anemia of End Stage Renal Disease
      • Specimen collection
      • Louisville, Kentucky
      • +2 more
      Jul 1, 2021